← FDA Drug Approvals (Drugs@FDA)

EFAVIRENZ

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN · Approved 2016-02-17

Drug application

FDA Application #

ANDA091471

Application type

Abbreviated New Drug Application (Generic)

Brand name

EFAVIRENZ

Generic name

Efavirenz

Active ingredients

EFAVIRENZ

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

MYLAN

First approval

2016-02-17

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown